Cargando…

Focal nodular hyperplasia after oxaliplatin-based chemotherapy: A diagnostic challenge()

Chemotherapy could induce benign liver alterations presenting as diffuse or focal lesions mimicking metastases. Oxaliplatin-induced vascular liver injury is described in literature, but the association with FNH-like lesions has been reported in a limited number of cases. We herewith describe the cas...

Descripción completa

Detalles Bibliográficos
Autores principales: Vassallo, Lorenzo, Fasciano, Mirella, Fortunato, Mirella, Orcioni, Giulio Fraternali, Vavala', Tiziana, Regge, Daniele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990178/
https://www.ncbi.nlm.nih.gov/pubmed/35401910
http://dx.doi.org/10.1016/j.radcr.2022.03.020
_version_ 1784683330802810880
author Vassallo, Lorenzo
Fasciano, Mirella
Fortunato, Mirella
Orcioni, Giulio Fraternali
Vavala', Tiziana
Regge, Daniele
author_facet Vassallo, Lorenzo
Fasciano, Mirella
Fortunato, Mirella
Orcioni, Giulio Fraternali
Vavala', Tiziana
Regge, Daniele
author_sort Vassallo, Lorenzo
collection PubMed
description Chemotherapy could induce benign liver alterations presenting as diffuse or focal lesions mimicking metastases. Oxaliplatin-induced vascular liver injury is described in literature, but the association with FNH-like lesions has been reported in a limited number of cases. We herewith describe the case of a 67-year-old male, who had laparoscopic right-sided hemicolectomy, 8 years ago, because of colonic adenocarcinoma (pT3N0M0) and subsequent adjuvant chemotherapy (capecitabine + oxaliplatin), who referred to the ultrasound service of our Radiology Unit because of abdominal pain. Five-years follow-up was negative for metastases. Ultrasound examination showed 2 small hypoechoic hepatic nodules, in segment VIII and VII, confirmed at CT, suspected for metastases. FDG-PET was negative, and blood tumor markers were within normal ranges. For further evaluation we performed gadoxetic acid (Gd-EOB-DTPA)-enhanced MRI that showed hyperintensity of the nodules in the hepatobiliary phase with central small hypointensity due to a central scar. Considering the previous oxaliplatin-based chemotherapy the findings were compatible with FNHlike lesions and the diagnostic suspicion was confirmed at ultrasound-guided core needle biopsy. Knowledge of the possible occurrence of FNH-like lesions in oncologic setting, along with the detection of typical MRI appearance, is important for appropriate management and may avoid unnecessary biopsy or surgery and reduce patients’ anxiety.
format Online
Article
Text
id pubmed-8990178
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-89901782022-04-09 Focal nodular hyperplasia after oxaliplatin-based chemotherapy: A diagnostic challenge() Vassallo, Lorenzo Fasciano, Mirella Fortunato, Mirella Orcioni, Giulio Fraternali Vavala', Tiziana Regge, Daniele Radiol Case Rep Case Report Chemotherapy could induce benign liver alterations presenting as diffuse or focal lesions mimicking metastases. Oxaliplatin-induced vascular liver injury is described in literature, but the association with FNH-like lesions has been reported in a limited number of cases. We herewith describe the case of a 67-year-old male, who had laparoscopic right-sided hemicolectomy, 8 years ago, because of colonic adenocarcinoma (pT3N0M0) and subsequent adjuvant chemotherapy (capecitabine + oxaliplatin), who referred to the ultrasound service of our Radiology Unit because of abdominal pain. Five-years follow-up was negative for metastases. Ultrasound examination showed 2 small hypoechoic hepatic nodules, in segment VIII and VII, confirmed at CT, suspected for metastases. FDG-PET was negative, and blood tumor markers were within normal ranges. For further evaluation we performed gadoxetic acid (Gd-EOB-DTPA)-enhanced MRI that showed hyperintensity of the nodules in the hepatobiliary phase with central small hypointensity due to a central scar. Considering the previous oxaliplatin-based chemotherapy the findings were compatible with FNHlike lesions and the diagnostic suspicion was confirmed at ultrasound-guided core needle biopsy. Knowledge of the possible occurrence of FNH-like lesions in oncologic setting, along with the detection of typical MRI appearance, is important for appropriate management and may avoid unnecessary biopsy or surgery and reduce patients’ anxiety. Elsevier 2022-04-05 /pmc/articles/PMC8990178/ /pubmed/35401910 http://dx.doi.org/10.1016/j.radcr.2022.03.020 Text en © 2022 The Authors. Published by Elsevier Inc. on behalf of University of Washington. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Vassallo, Lorenzo
Fasciano, Mirella
Fortunato, Mirella
Orcioni, Giulio Fraternali
Vavala', Tiziana
Regge, Daniele
Focal nodular hyperplasia after oxaliplatin-based chemotherapy: A diagnostic challenge()
title Focal nodular hyperplasia after oxaliplatin-based chemotherapy: A diagnostic challenge()
title_full Focal nodular hyperplasia after oxaliplatin-based chemotherapy: A diagnostic challenge()
title_fullStr Focal nodular hyperplasia after oxaliplatin-based chemotherapy: A diagnostic challenge()
title_full_unstemmed Focal nodular hyperplasia after oxaliplatin-based chemotherapy: A diagnostic challenge()
title_short Focal nodular hyperplasia after oxaliplatin-based chemotherapy: A diagnostic challenge()
title_sort focal nodular hyperplasia after oxaliplatin-based chemotherapy: a diagnostic challenge()
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990178/
https://www.ncbi.nlm.nih.gov/pubmed/35401910
http://dx.doi.org/10.1016/j.radcr.2022.03.020
work_keys_str_mv AT vassallolorenzo focalnodularhyperplasiaafteroxaliplatinbasedchemotherapyadiagnosticchallenge
AT fascianomirella focalnodularhyperplasiaafteroxaliplatinbasedchemotherapyadiagnosticchallenge
AT fortunatomirella focalnodularhyperplasiaafteroxaliplatinbasedchemotherapyadiagnosticchallenge
AT orcionigiuliofraternali focalnodularhyperplasiaafteroxaliplatinbasedchemotherapyadiagnosticchallenge
AT vavalatiziana focalnodularhyperplasiaafteroxaliplatinbasedchemotherapyadiagnosticchallenge
AT reggedaniele focalnodularhyperplasiaafteroxaliplatinbasedchemotherapyadiagnosticchallenge